PM
Prosight Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,000
| Closed | -$333K | – | 29 |
|
|
2022
Q1 | $333K | Sell |
20,000
-48,800
| -71% | -$813K | 0.22% | 29 |
|
|
2021
Q4 | $1.31M | Sell |
68,800
-205,961
| -75% | -$3.93M | 0.79% | 25 |
|
|
2021
Q3 | $6.78M | Buy |
274,761
+135,875
| +98% | +$3.35M | 3.73% | 7 |
|
|
2021
Q2 | $3.61M | Buy |
+138,886
| New | +$3.61M | 2.26% | 19 |
|
|
2020
Q4 | – | Sell |
-120,606
| Closed | -$3.97M | – | 42 |
|
|
2020
Q3 | $3.97M | Sell |
120,606
-94,394
| -44% | -$3.11M | 1.89% | 21 |
|
|
2020
Q2 | $5.9M | Sell |
215,000
-338,100
| -61% | -$9.28M | 2.53% | 15 |
|
|
2020
Q1 | $16.6M | Buy |
553,100
+164,500
| +42% | +$4.92M | 7.74% | 2 |
|
|
2019
Q4 | $10.8M | Buy |
388,600
+42,451
| +12% | +$1.17M | 4.72% | 7 |
|
|
2019
Q3 | $6.3M | Sell |
346,149
-53,851
| -13% | -$980K | 3.49% | 10 |
|
|
2019
Q2 | $9.81M | Sell |
400,000
-517,080
| -56% | -$12.7M | 4.95% | 5 |
|
|
2019
Q1 | $8.72M | Sell |
917,080
-145,420
| -14% | -$1.38M | 3.82% | 8 |
|
|
2018
Q4 | $9.4M | Buy |
1,062,500
+347,183
| +49% | +$3.07M | 4.85% | 7 |
|
|
2018
Q3 | $8.05M | Buy |
715,317
+275,417
| +63% | +$3.1M | 4.49% | 8 |
|
|
2018
Q2 | $5.63M | Buy |
439,900
+230,058
| +110% | +$2.94M | 4.13% | 9 |
|
|
2018
Q1 | $3.55M | Sell |
209,842
-297,010
| -59% | -$5.02M | 2.22% | 17 |
|
|
2017
Q4 | $4.06M | Buy |
+506,852
| New | +$4.06M | 2.98% | 14 |
|